The acceleration of precision diagnostics is largely driven by the sophisticated integration of artificial intelligence and machine learning within clinical workflows. Recent Minimal Residual Disease Testing Market Growth Dynamics indicate that AI algorithms are now capable of filtering out "genomic noise," allowing for a much clearer identification of true cancer signals in a sea of...